Galectin Therapeutics Inc. , a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases.
Galectin Therapeutics stock last closed at $1.37, up 2.24% from the previous day, and has decreased 48.5% in one year. It has overperformed other stocks in the Biotechnology industry by 0.28 percentage points. Galectin Therapeutics stock is currently +88.71% from its 52-week low of $0.73, and -56.78% from its 52-week high of $3.17.
At the moment, there are 63.29M GALT shares outstanding. The market capitalization of GALT is $86.71M. In the past 24 hours, 188,000 GALT shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy GALT stock.
Based on our analysis, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, the next step is to fill out some personal info so you can buy GALT stock today.
Now that you've created your account on mobile trading apps, your next step is to transfer the money for your investment:
Check out the tutorial below if you need help depositing funds into your brokerage account.
Once you have selected the best place to buy Galectin Therapeutics stock, it's very important to analyze their stock prior to buying, so you actually comprehend the risk as well as the opportunity.
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on GALT's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge GALT's true value.
You can do additional valuation analysis on GALT's stock here.
You can dive deeper into what analysts are forecasting on the Galectin Therapeutics stock forecast page.
In the last year, insiders at GALT have bought more shares than they have sold.
James C. Czirr, 10% Owner of GALT, was the latest GALT insider to buy. They bought $44,400.00 worth of GALT shares on Jun 6, 2025.
Research more about who owns GALT stock here.
No, Galectin Therapeutics doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two main order types:
Hit the Open button and your broker will place the order.
If you want additional assistance investing in stocks on eToro, click the how to video below:
Now that you own some shares in GALT, you'll want to stay up-to-date on your stock purchase.
Create a watchlist to monitor your GALT stock.
To reiterate, here are the 6 steps for buying Galectin Therapeutics stock:
If you require a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get updates on your investment in Galectin Therapeutics, add GALT to your watchlist below.